First Clinical Study Of The Anti-Signal Regulatory Protein-Alpha (Sirpa) Antibody Cc-95251 Combined With Rituximab In Patients With Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (Nhl)
CC-95251;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First Clinical Study Of The Anti-Signal Regulatory Protein-Alpha (Sirpa) Antibody Cc-95251 Combined With Rituximab In Patients With Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (Nhl) ### Output: CC-95251;Rituximab